These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 1582518
1. Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer. Sacks NP, Robertson JF, Ellis IO, Nicholson RI, Crocker J, Blamey RW. Eur J Surg Oncol; 1992 Apr; 18(2):98-102. PubMed ID: 1582518 [Abstract] [Full Text] [Related]
2. Prognostic value of argyrophylic nucleolar organiser regions (AgNORs) in breast lesions. Simha M, Menon M, Doctor V. Indian J Cancer; 1996 Jun; 33(2):76-85. PubMed ID: 8979469 [Abstract] [Full Text] [Related]
3. Nucleolar organizer regions in laryngeal cancer. Klatka J, Skomra D. Ann Univ Mariae Curie Sklodowska Med; 2001 Jun; 56():417-21. PubMed ID: 11977351 [Abstract] [Full Text] [Related]
4. [Clinical significance of argyrophilic nucleolar organizer regions (AgNOR) and microvessel quantitation by staining for factor VIII-related antigen as prognostic indicators in stage I breast cancer]. Ogawa Y, Chung YS, Nakata B, Takatsuka S, Maeda K, Sawada T, Kato Y, Yoshikawa K, Sowa M. Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():66-70. PubMed ID: 7747994 [Abstract] [Full Text] [Related]
5. Diagnostic relevance of silver stained nucleolar organizer region (AgNORs) in benign and malignant breast lesions. Agarwal PK, Mehrotra A, Chandra T. Indian J Exp Biol; 1995 Oct; 33(10):715-20. PubMed ID: 8575800 [Abstract] [Full Text] [Related]
6. The prognostic value of argyrophil nucleolar organiser regions (AgNORs) in colorectal cancer. Rayter Z, Surtees P, Tildsley G, Corbishley C. Eur J Surg Oncol; 1992 Feb; 18(1):37-40. PubMed ID: 1737591 [Abstract] [Full Text] [Related]
7. AgNOR counts have no prognostic value in breast cancer. Toikkanen S, Joensuu H. J Pathol; 1993 Feb; 169(2):251-4. PubMed ID: 8445490 [Abstract] [Full Text] [Related]
8. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions. Dasgupta A, Ghosh RN, Sarkar R, Laha RN, Ghosh TK, Mukherjee C. J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579 [Abstract] [Full Text] [Related]
10. The relationship between clinical staging, oestrogen receptor status and silver-binding nucleolar organiser regions (AgNOR) in breast carcinoma. Ohri AK, Ohri SK, Herbert A, Royle G, Taylor I. Eur J Surg Oncol; 1992 Apr; 18(2):103-7. PubMed ID: 1582501 [Abstract] [Full Text] [Related]
12. Prognostic value of nucleolar organiser regions (AgNORs) in laryngeal cancer. Krecicki T, Jeleń M, Zalesska-Krecicka M, Rak J, Szajowski K. Acta Otorhinolaryngol Belg; 1998 Apr; 52(3):215-21. PubMed ID: 9810456 [Abstract] [Full Text] [Related]
13. Evaluation of significance of AgNOR counts in differentiating benign from malignant lesions in the breast. Dube MK, Govil A. Indian J Pathol Microbiol; 1995 Jan; 38(1):5-10. PubMed ID: 8919463 [Abstract] [Full Text] [Related]
14. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis. Pich A, Chiusa L, Margaria E. Cancer Detect Prev; 1995 Jan; 19(3):282-91. PubMed ID: 7750118 [Abstract] [Full Text] [Related]
15. Prognostic significance of argyrophilic nucleolar organizer regions (AGNOR) in oesophageal cancer. Babu M, Mathur M, Gupta SD, Chattopadhyay TK. Trop Gastroenterol; 1996 Jan; 17(1):57-60. PubMed ID: 8693588 [Abstract] [Full Text] [Related]
16. AgNORs and their relationship to cell size, histological grade, lymph node involvement, metastases, and survival pattern in carcinoma of the breast: a study from south India. Subramanian S, Shariff S, Andrade C. J Surg Oncol; 1996 Jun; 62(2):139-43. PubMed ID: 8649041 [Abstract] [Full Text] [Related]
17. Nucleolar organizer regions: a prognostic factor in infiltrating ductal carcinoma in the breast. Canepa M, Gambini C, Borgiani L, Pastorino A, Buccaran G, Gallo L, Storace A, Rovida S. Pathologica; 1993 Jun; 85(1096):151-62. PubMed ID: 8395684 [Abstract] [Full Text] [Related]
18. Nucleolar organizer regions in human breast cancer. Roller E, Fritz P, Wicherek C, Klumpp B, Lauinger J, Mischlinski A, Wanner B, Schumacher K. Zentralbl Pathol; 1993 Aug; 139(3):195-9. PubMed ID: 8218120 [Abstract] [Full Text] [Related]